Drug Approval | February 08, 2022
Lupin receives approval from USFDA for Arformoterol Tartrate inhalation
Arformoterol Tartrate had estimated annual sales of US $ 251 million in the U.S. (IQVIA MAT December 2021)
Arformoterol Tartrate had estimated annual sales of US $ 251 million in the U.S. (IQVIA MAT December 2021)
Key takeaways of recent quarter & conference call highlights
Corbevax is administered through an intramuscular route with two doses scheduled 28 days apart and is stored between 2 degrees celsius to 8 degrees celsius
Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug
Their strong recommendation is based on moderate certainty evidence that it improves survival and reduces the need for ventilation
The study will be published on the pre-print server, medRXiv, shortly
Six months after receipt of the second Covaxin dose, participants received booster dose of the same. The trial demonstrated long-term safety with no serious events
The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
Decisions reaffirm the ability of Biocon Biologics and Viatris to provide patient access to interchangeable Semglee
Subscribe To Our Newsletter & Stay Updated
